Radical Catheter Technologies has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its 6F neurovascular access catheter.
6F is the company's third FDA-cleared catheter and is designed to broaden therapeutic options for middle-meningeal artery embolization and radial access procedures, according to the firm. It is built on patented ribbon technology intended to provide simultaneous flexibility, push, and stability, with a thinner wall construction that offers a greater inner diameter relative to outer diameter, Radical Catheter Technologies said.
